#72 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians should counsel male patients of reproductive age about potential cannabis use impacts on fertility, as emerging evidence suggests cannabinoids may disrupt hypothalamic-pituitary-gonadal axis function and reduce sperm quality. This information is particularly relevant during preconception counseling and when evaluating male factor infertility, as patients may not spontaneously report cannabis use or understand its reproductive consequences. Incorporating cannabis use screening into routine reproductive health assessments can help patients make informed decisions about substance use when fertility is a treatment goal.
Recent evidence suggests that cannabis use may impair male fertility through disruption of hypothalamic-pituitary-gonadal axis signaling, potentially reducing testosterone production and sperm quality. Research indicates that cannabinoids interfere with the brain’s hormonal regulation mechanisms that control reproductive function, with effects that may be dose and duration dependent. These findings are particularly relevant for clinicians counseling men of reproductive age who are current or contemplating cannabis users, as the fertility impacts may not be immediately apparent to patients. The mechanism appears to involve cannabinoid receptor signaling in brain regions critical for hormone secretion, suggesting that stopping use might partially reverse these effects, though this requires further investigation. Clinicians should incorporate cannabis use history into fertility assessments for male patients and discuss potential reproductive consequences, particularly for those planning to father children or with unexplained infertility.
“What we’re seeing in the literature is that regular cannabis use, particularly in younger men during their reproductive years, can suppress luteinizing hormone and disrupt the hypothalamic-pituitary-gonadal axis, which directly impacts sperm production and fertility, so this is a conversation I’m now initiating with male patients of childbearing age rather than waiting for them to ask.”
💙 While cannabis use has become increasingly normalized and legalized in many jurisdictions, emerging evidence suggests clinicians should counsel male patients about potential impacts on reproductive function. Research indicating cannabis may disrupt hypothalamic-pituitary-gonadal axis signaling and affect sperm parameters is preliminary but clinically relevant, particularly for men planning conception or experiencing unexplained infertility. Important caveats include the small sample sizes in many studies, variability in cannabis potency and consumption methods, and the difficulty isolating cannabis effects from confounding factors like smoking-related injury, lifestyle factors, or comorbid conditions. Given that many patients do not spontaneously disclose cannabis use to providers, routine sexual and reproductive history taking should include substance use assessment, and men of reproductive age who use cannabis should be informed of potential fertility concerns when counseling about family planning. A practical approach is to include cannabis use as a modifiable risk factor discussion for men presenting with inf
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
FAQ
This News item was assembled from structured source metadata and pipeline scoring.
Have thoughts on this? Share it:
